Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Vitamin K Antagonists (VKA) Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Oral Vitamin K Antagonists
      • 1.3.3 Injection Vitamin K Antagonists
    • 1.4 Market Segment by Application
      • 1.4.1 Global Vitamin K Antagonists (VKA) Market Share by Application (2019-2025)
      • 1.4.2 VTE
      • 1.4.3 ACS/MI
      • 1.4.4 AF
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Vitamin K Antagonists (VKA) Market Size
      • 2.1.1 Global Vitamin K Antagonists (VKA) Revenue 2014-2025
      • 2.1.2 Global Vitamin K Antagonists (VKA) Sales 2014-2025
    • 2.2 Vitamin K Antagonists (VKA) Growth Rate by Regions
      • 2.2.1 Global Vitamin K Antagonists (VKA) Sales by Regions 2014-2019
      • 2.2.2 Global Vitamin K Antagonists (VKA) Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Vitamin K Antagonists (VKA) Sales by Manufacturers
      • 3.1.1 Vitamin K Antagonists (VKA) Sales by Manufacturers 2014-2019
      • 3.1.2 Vitamin K Antagonists (VKA) Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Vitamin K Antagonists (VKA) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Vitamin K Antagonists (VKA) Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Vitamin K Antagonists (VKA) Market Concentration Ratio (CR5 and HHI)
    • 3.3 Vitamin K Antagonists (VKA) Price by Manufacturers
    • 3.4 Key Manufacturers Vitamin K Antagonists (VKA) Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Vitamin K Antagonists (VKA) Market
    • 3.6 Key Manufacturers Vitamin K Antagonists (VKA) Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Oral Vitamin K Antagonists Sales and Revenue (2014-2019)
      • 4.1.2 Injection Vitamin K Antagonists Sales and Revenue (2014-2019)
    • 4.2 Global Vitamin K Antagonists (VKA) Sales Market Share by Type
    • 4.3 Global Vitamin K Antagonists (VKA) Revenue Market Share by Type
    • 4.4 Vitamin K Antagonists (VKA) Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Vitamin K Antagonists (VKA) Sales by Application

    6 United States

    • 6.1 United States Vitamin K Antagonists (VKA) Breakdown Data by Company
    • 6.2 United States Vitamin K Antagonists (VKA) Breakdown Data by Type
    • 6.3 United States Vitamin K Antagonists (VKA) Breakdown Data by Application

    7 European Union

    • 7.1 European Union Vitamin K Antagonists (VKA) Breakdown Data by Company
    • 7.2 European Union Vitamin K Antagonists (VKA) Breakdown Data by Type
    • 7.3 European Union Vitamin K Antagonists (VKA) Breakdown Data by Application

    8 China

    • 8.1 China Vitamin K Antagonists (VKA) Breakdown Data by Company
    • 8.2 China Vitamin K Antagonists (VKA) Breakdown Data by Type
    • 8.3 China Vitamin K Antagonists (VKA) Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Vitamin K Antagonists (VKA) Breakdown Data by Company
    • 9.2 Rest of World Vitamin K Antagonists (VKA) Breakdown Data by Type
    • 9.3 Rest of World Vitamin K Antagonists (VKA) Breakdown Data by Application
    • 9.4 Rest of World Vitamin K Antagonists (VKA) Breakdown Data by Countries
      • 9.4.1 Rest of World Vitamin K Antagonists (VKA) Sales by Countries
      • 9.4.2 Rest of World Vitamin K Antagonists (VKA) Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Sanofi
      • 10.1.1 Sanofi Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Vitamin K Antagonists (VKA)
      • 10.1.4 Vitamin K Antagonists (VKA) Product Introduction
      • 10.1.5 Sanofi Recent Development
    • 10.2 Bristol-Myers Squibb
      • 10.2.1 Bristol-Myers Squibb Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Vitamin K Antagonists (VKA)
      • 10.2.4 Vitamin K Antagonists (VKA) Product Introduction
      • 10.2.5 Bristol-Myers Squibb Recent Development
    • 10.3 Bayer
      • 10.3.1 Bayer Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Vitamin K Antagonists (VKA)
      • 10.3.4 Vitamin K Antagonists (VKA) Product Introduction
      • 10.3.5 Bayer Recent Development
    • 10.4 Johnson & Johnson
      • 10.4.1 Johnson & Johnson Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Vitamin K Antagonists (VKA)
      • 10.4.4 Vitamin K Antagonists (VKA) Product Introduction
      • 10.4.5 Johnson & Johnson Recent Development
    • 10.5 Genentech (Roche)
      • 10.5.1 Genentech (Roche) Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Vitamin K Antagonists (VKA)
      • 10.5.4 Vitamin K Antagonists (VKA) Product Introduction
      • 10.5.5 Genentech (Roche) Recent Development
    • 10.6 Boehringer Ingelheim
      • 10.6.1 Boehringer Ingelheim Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Vitamin K Antagonists (VKA)
      • 10.6.4 Vitamin K Antagonists (VKA) Product Introduction
      • 10.6.5 Boehringer Ingelheim Recent Development
    • 10.7 Lilly
      • 10.7.1 Lilly Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Vitamin K Antagonists (VKA)
      • 10.7.4 Vitamin K Antagonists (VKA) Product Introduction
      • 10.7.5 Lilly Recent Development
    • 10.8 Daiichi Sankyo
      • 10.8.1 Daiichi Sankyo Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Vitamin K Antagonists (VKA)
      • 10.8.4 Vitamin K Antagonists (VKA) Product Introduction
      • 10.8.5 Daiichi Sankyo Recent Development
    • 10.9 Otsuka
      • 10.9.1 Otsuka Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Vitamin K Antagonists (VKA)
      • 10.9.4 Vitamin K Antagonists (VKA) Product Introduction
      • 10.9.5 Otsuka Recent Development
    • 10.10 AstraZeneca
      • 10.10.1 AstraZeneca Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Vitamin K Antagonists (VKA)
      • 10.10.4 Vitamin K Antagonists (VKA) Product Introduction
      • 10.10.5 AstraZeneca Recent Development
    • 10.11 Pfizer
    • 10.12 Aspen
    • 10.13 The Medicines Company

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Vitamin K Antagonists (VKA) Sales Channels
      • 11.2.2 Vitamin K Antagonists (VKA) Distributors
    • 11.3 Vitamin K Antagonists (VKA) Customers

    12 Market Forecast

    • 12.1 Global Vitamin K Antagonists (VKA) Sales and Revenue Forecast 2019-2025
    • 12.2 Global Vitamin K Antagonists (VKA) Sales Forecast by Type
    • 12.3 Global Vitamin K Antagonists (VKA) Sales Forecast by Application
    • 12.4 Vitamin K Antagonists (VKA) Forecast by Regions
      • 12.4.1 Global Vitamin K Antagonists (VKA) Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Vitamin K Antagonists (VKA) Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Vitamin K is a kind of substance with biological activity of leaf green quinone.
      Rising demand from Asia-Pacific region a major driver for the growth of the market.
      In 2019, the market size of Vitamin K Antagonists (VKA) is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Vitamin K Antagonists (VKA).

      This report studies the global market size of Vitamin K Antagonists (VKA), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Vitamin K Antagonists (VKA) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Sanofi
      Bristol-Myers Squibb
      Bayer
      Johnson & Johnson
      Genentech (Roche)
      Boehringer Ingelheim
      Lilly
      Daiichi Sankyo
      Otsuka
      AstraZeneca
      Pfizer
      Aspen
      The Medicines Company

      Market Segment by Product Type
      Oral Vitamin K Antagonists
      Injection Vitamin K Antagonists

      Market Segment by Application
      VTE
      ACS/MI
      AF
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Vitamin K Antagonists (VKA) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Vitamin K Antagonists (VKA) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Vitamin K Antagonists (VKA) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now